Development of a next-generation chikungunya virus vaccine based on the HydroVax platform. by Dawn K Slifka, Hans-Peter Raué, Whitney C Weber, Takeshi F Andoh, Craig N Kreklywich, Victor R DeFilippis, Daniel N Streblow, Mark K Slifka, Ian J Amanna

Get full text

GM-CSF production allows the identification of immunoprevalent antigens recognized by human CD4+ T cells following smallpox vaccination. by Valeria Judkowski, Alcinette Bunying, Feng Ge, Jon R Appel, Kingyee Law, Atima Sharma, Claudia Raja-Gabaglia, Patricia Norori, Radleigh G Santos, Marc A Giulianotti, Mark K Slifka, Daniel C Douek, Barney S Graham, Clemencia Pinilla

Get full text

Development of a virulent O'nyong'nyong challenge model to determine heterologous protection mediated by a hydrogen peroxide-inactivated chikungunya virus vaccine. by Whitney C Weber, Zachary J Streblow, Takeshi F Andoh, Michael Denton, Hans-Peter Raué, Ian J Amanna, Dawn K Slifka, Craig N Kreklywich, Irene Arduino, Gauthami Sulgey, Magdalene M Streblow, Mark T Heise, Mark K Slifka, Daniel N Streblow

Get full text

Effect of obesity on the acute response to SARS-CoV-2 infection and development of post-acute sequelae of COVID-19 (PASC) in nonhuman primates by Kristin A. Sauter, Gabriela M. Webb, Lindsay Bader, Craig N. Kreklywich, Diana L. Takahashi, Cicely Zaro, Casey M. McGuire, Anne D. Lewis, Lois M. A. Colgin, Melissa A. Kirigiti, Hannah Blomenkamp, Cleiton Pessoa, Matthew Humkey, Jesse Hulahan, Madeleine Sleeman, Robert C. Zweig, Sarah Thomas, Archana Thomas, Lina Gao, Alec J. Hirsch, Maayan Levy, Sara Cherry, Steven E. Kahn, Mark K. Slifka, Daniel N. Streblow, Jonah B. Sacha, Paul Kievit, Charles T. Roberts

Get full text